Navigation Links
Schizophrenia Tied to Multiple Genetic Errors
Date:3/27/2008

Finding could lead to specific treatments for individual patients, study says

THURSDAY, March 27 (HealthDay News) -- Scientists have found that deletions and duplications in DNA are more common in people with schizophrenia, and these errors are in genes related to brain development and neurological function.

Because these deletions and duplications differ from person to person, the study findings could eventually lead to new individualized treatments for those suffering from the disabling mental disorder, the researchers said.

"We found areas in people's DNA that are either deleted or duplicated -- we all have some of these, and some are rare," said lead researcher Dr. Jon M. McClellan, an associate professor of psychiatry at the University of Washington, in Seattle. "The assumption is that common ones are probably less likely to cause illnesses, but the rare ones might."

The researchers looked to see if people with schizophrenia had more rare mutations than healthy individuals did. "We found they had a lot more," McClellan said. "So there was about a threefold increased risk of having a rare deletion or duplication in someone with schizophrenia versus healthy people."

For those who developed schizophrenia early in life, there was a fourfold increased risk of rare deletions and duplications, McClellan added.

The findings were published in the March 27 edition of the journal Science.

For the study, McClellan's team analyzed DNA from 150 people with schizophrenia and 268 people without the disease. The researchers found deletions and duplications of genes in 15 percent of those with schizophrenia, compared to only 5 percent among people without the disorder.

Genetic deletions and duplications were even greater among people whose schizophrenia started when they were young -- before 12 years of age. Among these people, 20 percent had the rare gene mutations.

The results were confirmed by a second team of researchers led by Anjene Addington and Judith Rapoport at the U.S. National Institutes of Mental Health. In their study, Addington and Rapoport found that the rate of rare duplications and deletions of genes was even higher among people who developed schizophrenia before they were 12 years old.

Among people with schizophrenia, these mutations were likely to alter genes that help in brain development. While each mutation was unique and affected different genes, several mutations were related to parts of the brain that control neurobiological development, the researchers found.

McClellan noted that many different mutations in many genes can disrupt brain development resulting in schizophrenia. Therefore, in people with schizophrenia, the genetic causes may be different for different people, he said.

"If it's the case that most people have a different genetic cause for schizophrenia, the way that most research is done now isn't going to work," McClellan said. Current research is designed to find commonalities between people with schizophrenia, he said, adding, "That may not be the best way to go."

The encouraging news is that new technologies are available that can find these rare gene mutations in individual patients with schizophrenia. And, as these technologies improve, it may one day be possible to develop new treatments targeted for specific genes in affected individuals, McClellan said.

One mental-health expert thinks these findings could serve as a breakthrough in understanding schizophrenia.

"This is a groundbreaking study which presents a novel approach to identifying genetic factors predisposing to schizophrenia," said Dr. Daphne Holt, an instructor in medicine at Harvard Medical School, and associate director of the Massachusetts General Hospital First Episode and Early Psychosis Program.

"The idea that multiple rare mutations may account for a substantial portion of the incidence of schizophrenia is at variance with the current dogma of the field, which is that a number of mildly deleterious, common alleles [genes] combine with environmental factors to lead to the development of schizophrenia," Holt said.

"I believe that this study could lead to a change in the overall direction of the field, and I look forward to further replication and extension of these findings," Holt said.

According to the National Institute of Mental Health, schizophrenia affects about 1.1 percent of the adult American population in a given year. People with schizophrenia sometimes hear voices others don't hear, believe that others are broadcasting their thoughts to the world, or become convinced that others are trying to harm them. These experiences can make them fearful and withdrawn and make it difficult to have relationships with other people.

More information

For more on schizophrenia, visit the U.S. National Institute of Mental Health.



SOURCES: Jon M. McClellan, M.D., associate professor, psychiatry, University of Washington, Seattle; Daphne Holt, M.D., Ph.D., instructor, medicine, Harvard Medical School, and associate director, Massachusetts General Hospital First Episode and Early Psychosis Program, Boston; March 27, 2008, Science


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
2. Normal role for schizophrenia risk gene identified
3. Schizophrenia Gene May Have On/Off Switch
4. Potential new approach to treat cognitive impairments in schizophrenia
5. Schizophrenia candidate genes affect even healthy individuals
6. Hearing messages embedded in noise could be early sign of schizophrenia
7. People with Schizophrenia More Likely to Die of Heart Disease, Reports the Harvard Mental Health Letter
8. US FDA approves ABILIFY for adolescent patients with schizophrenia
9. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
10. Study Shows Organons Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
11. Genes Yield More Clues to Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Schizophrenia Tied to Multiple Genetic Errors
(Date:5/4/2016)... ... 04, 2016 , ... Trinity Health today launched its inaugural ... aimed at improving care and reducing readmission rates for patients who are dually ... Health is to drive innovation that transforms our ministry and our industry to ...
(Date:5/4/2016)... SCOTTSDALE, AZ (PRWEB) , ... May 04, 2016 ... ... 2016 Annual Technology & Business Conference. The conference opened on Tuesday with Frank ... panel discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model ...
(Date:5/4/2016)... ... ... Level 10 Head Over Heels Athletic Arts’ gymnast Alessandra Brovedani -- who goes ... fall of 2019. , After a handful of college visits, the Berkeley High ... her connection with the coaching staff and the excitement surrounding Wildcat Athletics. , “What ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... therapy products, announced today the introduction of the innovative newly improved Iso-Hip Wrap. ... hip replacement patients. The plush design enhances comfort and enables the patient to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Nike Rugby Camp's ... rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike Camp ... players every year since 2009. , “I’m excited for our eighth summer here ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... May 3, 2016  Forté Elements, LLC (Forté) is excited to announce the launch ... address the nutritional needs of recovery for a variety of clinical conditions. Founded in ... Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)...  Deerfield announced today it led the $44.5 ... Graybug Vision is an early stage pharmaceutical company ... for ocular diseases including wet age-related macular degeneration ... developed at Johns Hopkins University and has been ... Graybug Vision is developing ophthalmology products enabling ...
Breaking Medicine Technology: